Artificial intelligence and machine learning have the potential to make cancer care more accessible, efficient, cost-effective and personalized. However, meticulously planned prospective deployment strategies are required to validate the performance of these technologies in real-world clinical settings and overcome the human trust barrier.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Quantum deep reinforcement learning for clinical decision support in oncology: application to adaptive radiotherapy
Scientific Reports Open Access 07 December 2021
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Schwartz, W. B., Patil, R. S. & Szolovits, P. Artificial intelligence in medicine. N. Engl. J. Med. 316, 685–688 (1987).
Kann, B. H., Thompson, R., Thomas, C. R. Jr., Dicker, A. & Aneja, S. Artificial intelligence in oncology: current applications and future directions. Oncology (Williston Park). 33, 46–53 (2019).
El Naqa, I., Haider, M. A., Giger, M. L. & Ten Haken, R. K. Artificial Intelligence: reshaping the practice of radiological sciences in the 21st century. Br. J. Radiol. 93, 20190855 (2020).
McIntosh, C., Conroy, L. & Tjong, M. C. Clinical integration of machine learning for curative-intent radiation treatment of patients with prostate cancer. Nat. Med. 27, 999–1005 (2021).
Huynh, E., Hosny, A. & Guthier, C. Artificial intelligence in radiation oncology. Nat. Rev. Clin. Oncol. 17, 771–781 (2020).
Wong, J., Fong, A. & McVicar, N. Comparing deep learning-based auto-segmentation of organs at risk and clinical target volumes to expert inter-observer variability in radiotherapy planning. Radiother. Oncol. 144, 152–158 (2020).
Wang, M., Zhang, Q., Lam, S., Cai, J. & Yang, R. A review on application of deep learning algorithms in external beam radiotherapy automated treatment planning. Front.Oncol. 10, 580919–580919 (2020).
Cui, S., Tseng, H. H., Pakela, J., Ten Haken, R. K. & El Naqa, I. Introduction to machine and deep learning for medical physicists. Med Phys. 47, e127–e147 (2020).
Tseng H.-H., Luo Y., Ten Haken R. K. & El Naqa, I. The role of machine learning in knowledge-based response-adapted radiotherapy. Front. Oncol. 8, 266 (2018).
Shah, P., Kendall, F. & Khozin, S. Artificial intelligence and machine learning in clinical development: a translational perspective. NPJ Digit. Med. 2, 69 (2019).
Acknowledgements
The author gratefully acknowledges research funding from the US National Institutes of Health (grants R37-CA222215, R01-CA233487 and R41-CA243722, and contract 75N92020D00018).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author has acted as an advisor of Endectra LLC.
Rights and permissions
About this article
Cite this article
El Naqa, I. Prospective clinical deployment of machine learning in radiation oncology. Nat Rev Clin Oncol 18, 605–606 (2021). https://doi.org/10.1038/s41571-021-00541-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-021-00541-w
This article is cited by
-
Artificial intelligence applications in prostate cancer
Prostate Cancer and Prostatic Diseases (2024)
-
Translation of AI into oncology clinical practice
Oncogene (2023)
-
Quantum deep reinforcement learning for clinical decision support in oncology: application to adaptive radiotherapy
Scientific Reports (2021)